Background It is unknown whether implantable cardioverter-defibrillator (ICD) discharges
actively contribute to a worse prognosis independent of the underlying arrhythmia. There is …

Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Aims To report 5-year outcomes of EFFORTLESS registry patients with early generation
subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods and results …

Abstract Subcutaneous ICD (S-ICD™) therapy has been established in initial clinical trials
and current international guideline recommendations for patients without demand for …

Sudden cardiac death is a major public health issue in Canada. However, despite the
overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in …

Background: Ventricular fibrillation (VF) storm after myocardial infarction (MI) is a life-
threatening condition that necessitates multiple defibrillations. Catheter ablation is a …

Abstract This Canadian Cardiovascular Society position statement is focused on the
management of sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) that …

Background Electrical storm (ES) is defined as 3 or more episodes of ventricular fibrillation
(VF) or ventricular tachycardia (VT) within 24 hours and is associated with increased cardiac …

Aims Longevity of implantable cardioverter defibrillators (ICDs) is crucial for patients and
healthcare systems as replacements impact on infection rates and cost-effectiveness. Aim …

ATP and Mortality in 69,000 ICD Patients Aims Antitachycardia pacing (ATP) is an effective
treatment for ventricular tachycardia (VT) and can reduce the frequency of shocks in patients …